News

OncoSec will pay Inovio an undisclosed purchase price for the assigned assets and cash fees and a royalty on commercial product sales. The electroporation technology being sold and

Most recently, Robinson has worked as the CEO of WorkWell Systems and held senior roles at UnitedHealth Group, Deloitte Consulting and PriceWaterhouseCoopers in his career. LifeVantage board of

AN2728 is a boron-based small-molecule compound which reduces the production pro-inflammatory cytokines that are the precursors of the inflammation associated with psoriasis. The double-blind, randomised, vehicle-controlled Phase 2b

The Phase I open-label, dose-escalation study will dose up to 16 patients and will determine the maximum tolerated dose (MTD) of Imprime PGG in combination with alemtuzumab and

The company has generated net income of $13.32m, compared to a net income of $1.74m for the same period in 2009. Medidata has reported operating income of $9.91m

According to Bayer HealthCare, Gadavist demonstrated improvement of visualization endpoints in paired Gadavist images compared to pre-contrast images resulted in improved assessment of normal and abnormal CNS anatomy

The patent (US 7,902,152), entitled ‘Use of cobratoxin as an analgesic,’ describes a composition of matter for an analgesia and its method of use. The method of use

Additionally, Biosearch will develop cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics. Biosearch Technologies Corporate Development director Marc Beal said IMDx’s assays, powered by BHQ probing

Lubrizol produces and supplies technologies to customers in the global transportation, industrial and consumer markets. Lubrizol makes ingredients and additives for personal care products and pharmaceuticals; specialty materials,